4
Changes in Ownership
MYRIAD GENETICS INC Filed Acc 0001219036-21-000016
Chief Scientific Officer sold 50,000 shares at an average $32.62 ($1,631,037)
- Chief Scientific Officer acquired 50,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
LANCHBURY JERRY S · Chief Scientific Officer
Table I: Non-derivative
6 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-07-09 | Exercise or conversion : show line 1 in the form | +26,705 | $26.49 | $707,415 | 259,255 | D |
| 2021-07-09 | Sale : show line 2 in the form | −26,705 | $32.79 | $875,657 | 232,550 | D |
| 2021-07-09 | Exercise or conversion : show line 3 in the form | +5,603 | $26.49 | $148,423 | 238,153 | D |
| 2021-07-09 | Sale : show line 4 in the form | −5,603 | $32.29 | $180,921 | 232,550 | D |
| 2021-07-09 | Exercise or conversion : show line 5 in the form | +17,692 | $19.47 | $344,463 | 250,242 | D |
| 2021-07-09 | Sale : show line 6 in the form | −17,692 | $32.47 | $574,459 | 232,550 | D |
| Open-market sales · 50,000 sh · avg $32.62 · $1,631,037 | ||||||
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-07-09 | Exercise or conversion : show line 7 in the form Non-Qualified Stock Option (right to buy) | −17,692 | 0 | D |
| 2021-07-09 | Exercise or conversion : show line 8 in the form Non-Qualified Stock Option (right to buy) | −26,705 | 115,123 | D |
| 2021-07-09 | Exercise or conversion : show line 9 in the form Non-Qualified Stock Option (right to buy) | −5,603 | 109,520 | D |
Loading xslF345X03/edgardoc.xml…